Company / AR per Share
Cue Biopharma, Inc. AR per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.09
FY2025
5-year range
$0.00 / $0.10
FY2021-FY2025
Trend
+348.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share changed +348% YoY in FY2025, a notable deviation from the 6-year average annual change of +380%.
Based on SEC 10-K filings.
0.09 in FY2025 with a 5-year CAGR of +10.9%.
Improved from $0.04 to $0.09 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- +270.1%
- 5-Year CAGR
- +10.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, ar per share increased 348.2% year-over-year.
- Peak ar per share was recorded in FY2021.
- Lowest ar per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -7.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.09 | +348.2% |
| FY2024 | $0.02 | -44.3% |
| FY2023 | $0.04 | +1931.8% |
| FY2022 | $0.00 | -98.3% |
| FY2021 | $0.10 | +94.0% |
| FY2020 | $0.05 | +46.3% |
| FY2019 | $0.04 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026